These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 34768950)

  • 21. Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer's Disease.
    Rai SN; Singh C; Singh A; Singh MP; Singh BK
    Mol Neurobiol; 2020 Jul; 57(7):3075-3088. PubMed ID: 32462551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxyurea attenuates oxidative, metabolic, and excitotoxic stress in rat hippocampal neurons and improves spatial memory in a mouse model of Alzheimer's disease.
    Brose RD; Lehrmann E; Zhang Y; Reeves RH; Smith KD; Mattson MP
    Neurobiol Aging; 2018 Dec; 72():121-133. PubMed ID: 30245242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial Regulation of Microglial Immunometabolism in Alzheimer's Disease.
    Fairley LH; Wong JH; Barron AM
    Front Immunol; 2021; 12():624538. PubMed ID: 33717134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PGC-1α overexpression exacerbates β-amyloid and tau deposition in a transgenic mouse model of Alzheimer's disease.
    Dumont M; Stack C; Elipenahli C; Jainuddin S; Launay N; Gerges M; Starkova N; Starkov AA; Calingasan NY; Tampellini D; Pujol A; Beal MF
    FASEB J; 2014 Apr; 28(4):1745-55. PubMed ID: 24398293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synaptosomal Mitochondrial Dysfunction in 5xFAD Mouse Model of Alzheimer's Disease.
    Wang L; Guo L; Lu L; Sun H; Shao M; Beck SJ; Li L; Ramachandran J; Du Y; Du H
    PLoS One; 2016; 11(3):e0150441. PubMed ID: 26942905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nrf2 activation through the PI3K/GSK-3 axis protects neuronal cells from Aβ-mediated oxidative and metabolic damage.
    Sotolongo K; Ghiso J; Rostagno A
    Alzheimers Res Ther; 2020 Jan; 12(1):13. PubMed ID: 31931869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Future Therapeutic Perspectives into the Alzheimer's Disease Targeting the Oxidative Stress Hypothesis.
    Teixeira JP; de Castro AA; Soares FV; da Cunha EFF; Ramalho TC
    Molecules; 2019 Dec; 24(23):. PubMed ID: 31816853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.
    Manczak M; Reddy PH
    Hum Mol Genet; 2012 Dec; 21(23):5131-46. PubMed ID: 22926141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mitocentric view of Alzheimer's disease suggests multi-faceted treatments.
    Gibson GE; Shi Q
    J Alzheimers Dis; 2010; 20 Suppl 2(0 2):S591-607. PubMed ID: 20463407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevating the Levels of Calcium Ions Exacerbate Alzheimer's Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau.
    Guan PP; Cao LL; Wang P
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Newly Synthesized Rhamnoside Derivative Alleviates Alzheimer's Amyloid-
    Li Y; Lu J; Cao X; Zhao H; Gao L; Xia P; Pei G
    Oxid Med Cell Longev; 2020; 2020():7698560. PubMed ID: 32104538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular and Cellular Basis of Neurodegeneration in Alzheimer's Disease.
    Jeong S
    Mol Cells; 2017 Sep; 40(9):613-620. PubMed ID: 28927263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aging-Dependent Mitophagy Dysfunction in Alzheimer's Disease.
    Song M; Zhao X; Song F
    Mol Neurobiol; 2021 May; 58(5):2362-2378. PubMed ID: 33417222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Tau Protein on Mitochondrial Functions.
    Epremyan KK; Goleva TN; Zvyagilskaya RA
    Biochemistry (Mosc); 2022 Aug; 87(8):689-701. PubMed ID: 36171651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative Damage and Antioxidant Response in Frontal Cortex of Demented and Nondemented Individuals with Alzheimer's Neuropathology.
    Fracassi A; Marcatti M; Zolochevska O; Tabor N; Woltjer R; Moreno S; Taglialatela G
    J Neurosci; 2021 Jan; 41(3):538-554. PubMed ID: 33239403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial Calcium Deregulation in the Mechanism of Beta-Amyloid and Tau Pathology.
    Esteras N; Abramov AY
    Cells; 2020 Sep; 9(9):. PubMed ID: 32967303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease.
    Reddy PH
    Brain Res; 2011 Sep; 1415():136-48. PubMed ID: 21872849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial dysfunction: different routes to Alzheimer's disease therapy.
    Picone P; Nuzzo D; Caruana L; Scafidi V; Di Carlo M
    Oxid Med Cell Longev; 2014; 2014():780179. PubMed ID: 25221640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer's Disease.
    Kim J
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.